尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the full record of transactions filed by Scheinberg David A, 董事. Officer active across 1 company, notably SELLAS Life Sciences Group, Inc.. In total, 5 reports have been logged. History available since 31 January 2022. The latest transaction was disclosed on 7 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
David A. Scheinberg is a Director at SELLAS Life Sciences Group, Inc. He participates in strategic decisions and the governance of the company. His experience in the life sciences sector allows him to provide significant contributions to board discussions.